首页> 外文期刊>Journal of Oral and Maxillofacial Surgery >Adipose stem cell tissue-engineered construct used to treat large anterior mandibular defect: A case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration
【24h】

Adipose stem cell tissue-engineered construct used to treat large anterior mandibular defect: A case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration

机译:脂肪干细胞组织工程构建体用于治疗前下颌大骨缺损:一例报告并回顾了良好生产水平的脂肪干细胞用于骨再生的临床应用

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Large mandibular resection defects historically have been treated using autogenous bone grafts and reconstruction plates. However, a major drawback of large autogenous bone grafts is donor-site morbidity. Patients and Methods: This report describes the replacement of a 10-cm anterior mandibular ameloblastoma resection defect, reproducing the original anatomy of the chin, using a tissue-engineered construct consisting of β-tricalcium phosphate (β-TCP) granules, recombinant human bone morphogenetic protein-2 (BMP-2), and Good Manufacturing Practice-level autologous adipose stem cells (ASCs). Unlike prior reports, 1-step in situ bone formation was used without the need for an ectopic bone-formation step. The reconstructed defect was rehabilitated with a dental implant-supported overdenture. An additive manufactured medical skull model was used preoperatively to guide the prebending of patient-specific hardware, including a reconstruction plate and titanium mesh. A subcutaneous adipose tissue sample was harvested from the anterior abdominal wall of the patient before resection and simultaneous reconstruction of the parasymphysis. ASCs were isolated and expanded ex vivo over the next 3 weeks. The cell surface marker expression profile of ASCs was similar to previously reported results and ASCs were analyzed for osteogenic differentiation potential in vitro. The expanded cells were seeded onto a scaffold consisting of β-TCP and BMP-2 and the cell viability was evaluated. The construct was implanted into the parasymphyseal defect. Results: Ten months after reconstruction, dental implants were inserted into the grafted site, allowing harvesting of bone cores. Histologic examination and in vitro analysis of cell viability and cell surface markers were performed and prosthodontic rehabilitation was completed. Conclusion: ASCs in combination with β-TCP and BMP-2 offer a promising construct for the treatment of large, challenging mandibular defects without the need for ectopic bone formation and allowing rehabilitation with dental implants.
机译:目的:历史上已经使用自体骨移植物和重建板治疗了大的下颌切除缺损。然而,大型自体骨移植的主要缺点是供体部位发病率。患者和方法:本报告介绍了使用由β-磷酸三钙(β-TCP)颗粒,重组人骨组成的组织工程构造物,替换10厘米的下颌前成纤维细胞瘤切除缺损,重现下巴的原始解剖结构形态发生蛋白2(BMP-2)和良好生产规范水平的自体脂肪干细胞(ASC)。与先前的报告不同,无需异位骨形成步骤就使用了1步原位骨形成。用种植牙支持的覆盖义齿修复了重建的缺损。术前使用增材制造的医用颅骨模型来指导患者特定硬件的预弯曲,包括重建板和钛网。在切除并同时重建副旁突之前,从患者的前腹壁采集皮下脂肪组织样品。分离了ASC,并在接下来的3周中离体扩增。 ASC的细胞表面标志物表达谱与先前报道的结果相似,并且分析了ASC的体外成骨分化潜能。将扩增的细胞接种到由β-TCP和BMP-2组成的支架上,并评估细胞活力。该构建体被植入到肩突旁缺损中。结果:重建十个月后,将牙种植体插入移植部位,从而收获骨核。进行组织学检查以及细胞活力和细胞表面标志物的体外分析,并完成了修复修复。结论:ASC与β-TCP和BMP-2的结合提供了一种有前途的构建体,可用于治疗具有挑战性的下颌大骨缺损,而无需异位骨形成并允许使用牙科植入物进行修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号